Details of the Drug

General Information of Drug (ID: DM6MO9X)

• Drug Name: Insulin Zinc Susp Recombinant Human
• Synonyms: Humulin L; Humulin U; Lentard; Lente; Lente Iletin Ii; Lente Iletin Ii (Pork); Lente Insulin; Novolin L; Semilente; Semilente Insulin; Ultralente; Ultralente Insulin; Insulin Zinc Susp Beef; Insulin Zinc Susp Extended Beef; Insulin Zinc Susp Extended Purified Beef; Insulin Zinc Susp Extended Recombinant Human; Insulin Zinc Susp Prompt Beef; Insulin Zinc Susp Prompt Purified Pork; Insulin Zinc Susp Purified Beef; Insulin Zinc Susp Purified Beef/Pork; Insulin Zinc Susp Purified Pork; Insulin Zinc Susp Semisynthetic Purified Human

Indication

Disease Entry	ICD 11	Status	REF
Diabetic complication	5A2Y	Approved	[1]

• Cross-matching ID: TTD ID: D03FIL

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Insulin (INS)	TTZOPHG	INS_HUMAN	Modulator	[2]

Molecular Expression Atlas of This Drug

• The Studied Disease: Diabetic complication
• ICD Disease Classification: 5A2Y

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Insulin (INS)	DTT	INS	6.70E-01	-0.12	-0.46

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.